Oncology Medications
Cancer therapies, including cytotoxic chemotherapy, targeted small molecules, antibody-drug conjugates, and immune checkpoint inhibitors.
275 medications
Abemaciclib
CDK4/6 Inhibitor (Protein Kinase Inhibitor)
Abiraterone
CYP17 Inhibitor (Androgen Biosynthesis Inhibitor)
Acalabrutinib
BTK Inhibitor (Protein Kinase Inhibitor)
Adagrasib
KRAS G12C Inhibitor
Afatinib
ErbB Family Blocker (Protein Kinase Inhibitor)
Aflibercept
VEGF Inhibitor (Recombinant Fusion Protein)
Aldesleukin
Interleukin-2 (Recombinant Cytokine Immunostimulant)
Alectinib
ALK Inhibitor (Protein Kinase Inhibitor)
Alpelisib
PI3Kα Inhibitor (Kinase Inhibitor)
Amivantamab
EGFR–MET Bispecific Antibody (Monoclonal Antibody)
Amsacrine
Aminoacridine Cytotoxic (DNA Intercalator, Topoisomerase II Inhibitor)
Anagrelide
Platelet-Lowering Agent (Other Antineoplastic Agent)
Anastrozole
Aromatase Inhibitor (Non-Steroidal)
Apalutamide
Androgen Receptor Inhibitor (Anti-Androgen)
Aprepitant
NK1 Receptor Antagonist (Antiemetic)
Asciminib
BCR::ABL1 Inhibitor (Allosteric Tyrosine Kinase Inhibitor)
Asparaginase
Asparagine-Depleting Enzyme (Antineoplastic)
Atezolizumab
PD-L1 Inhibitor (Monoclonal Antibody)
Avapritinib
KIT/PDGFRA Kinase Inhibitor (Protein Kinase Inhibitor)
Avelumab
PD-L1 Inhibitor (Monoclonal Antibody)
Axitinib
VEGFR Inhibitor (Protein Kinase Inhibitor)
Azacitidine
Hypomethylating Agent (Pyrimidine Analogue)
BCG Intravesical Therapy
Bladder Cancer Immunotherapy
Belantamab Mafodotin
BCMA-Directed Antibody–Drug Conjugate
Belzutifan
HIF-2α Inhibitor
Bendamustine
Alkylating Agent (Nitrogen Mustard Derivative)
Bevacizumab
VEGF Inhibitor (Antiangiogenic Monoclonal Antibody)
Bexarotene
Retinoid (Retinoid X Receptor Agonist)
Bicalutamide
Non-Steroidal Antiandrogen
Binimetinib
MEK1/2 Inhibitor (Protein Kinase Inhibitor)
Bleomycin
Cytotoxic Antibiotic (Antineoplastic)
Blinatumomab
Bispecific T-Cell Engager (CD19/CD3)
Bortezomib
Proteasome Inhibitor
Bosutinib
BCR-ABL Tyrosine Kinase Inhibitor (Protein Kinase Inhibitor)
Brentuximab Vedotin
CD30-Directed Antibody-Drug Conjugate
Brigatinib
ALK Inhibitor (Protein Kinase Inhibitor)
Buserelin
GnRH Agonist (Gonadotropin-Releasing Hormone Analogue)
Busulfan
Alkylating Agent (Alkyl Sulfonate)
Cabazitaxel
Taxane (Antimicrotubule Agent)
Cabozantinib
Multi-Targeted Tyrosine Kinase Inhibitor
Camizestrant
Selective Oestrogen Receptor Degrader (SERD)
Capecitabine
Fluoropyrimidine Antimetabolite (Oral Fluorouracil Prodrug)
Capivasertib
AKT Inhibitor (Serine/Threonine Kinase Inhibitor)
Capmatinib
MET Inhibitor (Protein Kinase Inhibitor)
Carboplatin
Platinum-Based Antineoplastic Agent
Carfilzomib
Proteasome Inhibitor
Carmustine
Nitrosourea Alkylating Agent
Catumaxomab
Bispecific Trifunctional Antibody (EpCAM/CD3)
Cemiplimab
PD-1 Inhibitor (Monoclonal Antibody)
Ceritinib
ALK Inhibitor (Protein Kinase Inhibitor)
Cetuximab
EGFR Inhibitor (Monoclonal Antibody)
Chlorambucil
Nitrogen Mustard Alkylating Agent
Cisplatin
Platinum Compound (Cytotoxic Chemotherapy)
Cladribine
Purine Nucleoside Analogue (Antimetabolite)
Clofarabine
Purine Nucleoside Analogue (Antimetabolite)
Cobimetinib
MEK Inhibitor (Protein Kinase Inhibitor)
Crisantaspase
Asparaginase (Recombinant Erwinia chrysanthemi L-Asparaginase)
Crizotinib
ALK/ROS1 Inhibitor (Protein Kinase Inhibitor)
Cyclophosphamide
Alkylating Agent (Nitrogen Mustard Analogue)
Cyproterone
Antiandrogen (Progestogenic, Antigonadotropic)
Cytarabine
Antimetabolite (Pyrimidine Analogue)
Dabrafenib
BRAF Inhibitor (Protein Kinase Inhibitor)
Dacarbazine
Alkylating Cytostatic Agent
Dacomitinib
Pan-HER Tyrosine Kinase Inhibitor (EGFR)
Dactinomycin
Cytotoxic Antibiotic (Actinomycin)
Daratumumab
Anti-CD38 Monoclonal Antibody
Darbepoetin Alfa
Erythropoiesis-Stimulating Agent (Erythropoietin Analogue)
Darolutamide
Androgen Receptor Inhibitor (Anti-androgen)
Dasatinib
Tyrosine Kinase Inhibitor (BCR-ABL / SRC Family)
Datopotamab Deruxtecan
TROP2-Directed Antibody-Drug Conjugate
Daunorubicin
Anthracycline (Cytotoxic Antibiotic)
Daunorubicin/Cytarabine Liposomal
Liposomal Anthracycline/Cytarabine Combination
Decitabine
Hypomethylating Agent (Cytidine Nucleoside Analogue)
Decitabine/Cedazuridine
Hypomethylating Agent with Cytidine Deaminase Inhibitor
Degarelix
GnRH Antagonist (Androgen Deprivation Therapy)
Denosumab
RANKL Inhibitor (Monoclonal Antibody)
Dexamethasone
Corticosteroid (Glucocorticoid)
Dexrazoxane
Detoxifying Agent for Antineoplastic Treatment (Iron Chelator)
Dinutuximab Beta
Anti-GD2 Monoclonal Antibody (Chimeric IgG1)
Docetaxel
Taxane (Microtubule Stabiliser)
Dostarlimab
PD-1 Inhibitor (Monoclonal Antibody)
Doxorubicin
Anthracycline Chemotherapy
Durvalumab
PD-L1 Inhibitor (Monoclonal Antibody)
Efbemalenograstim Alfa
Long-Acting G-CSF (Fc Fusion Protein)
Elacestrant
Selective Oestrogen Receptor Degrader (SERD)
Elotuzumab
SLAMF7-Targeting Monoclonal Antibody (Immunostimulatory)
Elranatamab
BCMA×CD3 Bispecific T-Cell Engager (Monoclonal Antibody)
Encorafenib
BRAF Inhibitor (Protein Kinase Inhibitor)
Enfortumab Vedotin
Antibody-Drug Conjugate (Nectin-4-Directed)
Entrectinib
TRK/ROS1/ALK Inhibitor (Protein Kinase Inhibitor)
Enzalutamide
Androgen Receptor Inhibitor (Anti-Androgen)
Epcoritamab
CD20×CD3 Bispecific Antibody (T-Cell Engager)
Epirubicin
Anthracycline (Cytotoxic Antibiotic)
Epoetin Alfa
Erythropoiesis-Stimulating Agent (Recombinant Human Erythropoietin)
Epoetin Beta
Erythropoiesis-Stimulating Agent (Recombinant Human Erythropoietin)
Epoetin Theta
Erythropoiesis-Stimulating Agent (Recombinant Human Erythropoietin)
Epoetin Zeta
Erythropoiesis-Stimulating Agent (Recombinant Human Erythropoietin)
Erdafitinib
FGFR Inhibitor (Protein Kinase Inhibitor)
Eribulin
Microtubule Dynamics Inhibitor (Halichondrin Analogue)
Erlotinib
EGFR Tyrosine Kinase Inhibitor
Etoposide
Topoisomerase II Inhibitor (Podophyllotoxin Derivative)
Everolimus
mTOR Inhibitor (Protein Kinase Inhibitor; Immunosuppressant)
Exemestane
Steroidal Aromatase Inhibitor
Fedratinib
JAK2 Inhibitor (Protein Kinase Inhibitor)
Filgrastim
Granulocyte Colony-Stimulating Factor (G-CSF)
Fludarabine
Purine Analogue (Antimetabolite)
Fluorouracil
Antimetabolite (Pyrimidine Analogue)
Flutamide
Non-Steroidal Antiandrogen
Folinic Acid
Reduced Folate (Detoxifying Agent for Antineoplastic Treatment)
Fosaprepitant
NK1 Receptor Antagonist (Antiemetic)
Fruquintinib
VEGFR Tyrosine Kinase Inhibitor (Protein Kinase Inhibitor)
Fulvestrant
Selective Oestrogen Receptor Degrader (Antioestrogen)
Futibatinib
FGFR Inhibitor (Tyrosine Kinase Inhibitor)
Gefitinib
EGFR Tyrosine Kinase Inhibitor
Gemcitabine
Pyrimidine Nucleoside Analogue (Antimetabolite)
Gemtuzumab Ozogamicin
CD33-Directed Antibody-Drug Conjugate
Gilteritinib
FLT3/AXL Inhibitor (Protein Kinase Inhibitor)
Glasdegib
Hedgehog Pathway Inhibitor (Smoothened Antagonist)
Glofitamab
CD20×CD3 Bispecific T-Cell Engager (Monoclonal Antibody)
Glucarpidase
Recombinant Enzyme (Methotrexate Antidote)
Goserelin
LHRH Agonist (Gonadotropin-Releasing Hormone Analogue)
Granisetron
5-HT3 Receptor Antagonist (Antiemetic)
Histamine Dihydrochloride
Immunostimulant (Histamine, Adjunct to Interleukin-2)
Hydroxycarbamide
Antineoplastic (Ribonucleotide Reductase Inhibitor)
Ibandronic Acid
Bisphosphonate (Bone Resorption Inhibitor)
Ibrutinib
BTK Inhibitor (Protein Kinase Inhibitor)
Idarubicin
Anthracycline (Topoisomerase II Inhibitor)
Idelalisib
PI3K Delta Inhibitor (Protein Kinase Inhibitor)
Ifosfamide
Alkylating Agent (Oxazaphosphorine, Nitrogen Mustard Analogue)
Imatinib
Tyrosine Kinase Inhibitor
Imetelstat
Telomerase Inhibitor (Oligonucleotide)
Imlunestrant
Selective Oestrogen Receptor Degrader (SERD)
Inavolisib
PI3K Inhibitor (Mutant-Selective PI3Kα Degrader)
Inotuzumab Ozogamicin
CD22-Directed Antibody-Drug Conjugate (Calicheamicin)
Ipilimumab
CTLA-4 Inhibitor (Monoclonal Antibody)
Irinotecan
Topoisomerase I Inhibitor (Camptothecin Derivative)
Isatuximab
Anti-CD38 Monoclonal Antibody
Ivosidenib
Isocitrate Dehydrogenase-1 (IDH1) Inhibitor
Ixazomib
Proteasome Inhibitor
Lapatinib
HER2/EGFR Tyrosine Kinase Inhibitor
Larotrectinib
TRK Inhibitor (Protein Kinase Inhibitor)
Lazertinib
EGFR Tyrosine Kinase Inhibitor (Protein Kinase Inhibitor)
Lenvatinib
Multikinase Inhibitor (Receptor Tyrosine Kinase Inhibitor)
Letrozole
Aromatase Inhibitor (Non-Steroidal)
Leuprorelin
GnRH Agonist (Gonadotropin-Releasing Hormone Analogue)
Levofolinic Acid
Reduced Folate (Active Isomer of Folinic Acid)
Linvoseltamab
Bispecific Monoclonal Antibody (BCMA × CD3)
Lipegfilgrastim
Long-Acting G-CSF (Pegylated Colony-Stimulating Factor)
Lomustine
Nitrosourea Alkylating Agent
Loncastuximab Tesirine
CD19-Directed Antibody-Drug Conjugate
Lorlatinib
ALK/ROS1 Tyrosine Kinase Inhibitor (Protein Kinase Inhibitor)
Lurbinectedin
Alkylating Antineoplastic (Transcription Inhibitor)
Luspatercept
Erythroid Maturation Agent (Recombinant Fusion Protein)
Medroxyprogesterone
Progestogen (Hormonal Antineoplastic)
Megestrol
Progestogen (Hormonal Antineoplastic)
Melphalan
Alkylating Agent (Nitrogen Mustard Analogue)
Melphalan Flufenamide
Alkylating Agent (Peptide-Drug Conjugate)
Mercaptopurine
Purine Analogue (Antimetabolite)
Mesna
Uroprotective Agent (Detoxifying Agent for Antineoplastic Treatment)
Methotrexate
Antimetabolite (Folate Antagonist)
Midostaurin
Protein Kinase Inhibitor (FLT3/KIT Multi-Kinase Inhibitor)
Mifamurtide
Immunostimulant (Synthetic Muramyl Dipeptide Derivative)
Mirdametinib
MEK1/2 Inhibitor (Protein Kinase Inhibitor)
Mirvetuximab Soravtansine
Folate Receptor Alpha-Directed Antibody-Drug Conjugate
Mitomycin
Antitumor Antibiotic / Alkylating Agent
Mitotane
Adrenal Cytotoxic Agent (Antineoplastic)
Mitoxantrone
Anthracenedione (Topoisomerase II Inhibitor)
Mogamulizumab
Anti-CCR4 Monoclonal Antibody
Momelotinib
JAK/ACVR1 Inhibitor (Protein Kinase Inhibitor)
Mosunetuzumab
CD20/CD3 Bispecific T-Cell Engager (Monoclonal Antibody)
Nelarabine
Purine Nucleoside Analogue (Antimetabolite)
Neratinib
Irreversible Pan-ERBB Tyrosine Kinase Inhibitor
Netupitant/Palonosetron
NK1 and 5-HT3 Receptor Antagonist Combination (Antiemetic)
Nilotinib
BCR-ABL Tyrosine Kinase Inhibitor
Niraparib
PARP Inhibitor (Poly(ADP-Ribose) Polymerase Inhibitor)
Nirogacestat
Gamma-Secretase Inhibitor (Notch Pathway Inhibitor)
Nivolumab
PD-1 Inhibitor (Monoclonal Antibody)
Nogapendekin Alfa Inbakicept
IL-15 Receptor Agonist (Intravesical Immunotherapy)
Obinutuzumab
Anti-CD20 Monoclonal Antibody (Glycoengineered Type II)
Odronextamab
CD20xCD3 Bispecific Antibody (T-Cell Engager)
Olaparib
PARP Inhibitor (Poly(ADP-Ribose) Polymerase Inhibitor)
Ondansetron
5-HT3 Receptor Antagonist (Antiemetic)
Osimertinib
EGFR Tyrosine Kinase Inhibitor (Protein Kinase Inhibitor)
Oxaliplatin
Platinum Compound (Cytotoxic Antineoplastic Agent)
Paclitaxel
Taxane (Microtubule Stabiliser)
Padeliporfin
Photosensitiser for Photodynamic Therapy (Antineoplastic)
Palbociclib
CDK4/6 Inhibitor (Protein Kinase Inhibitor)
Palonosetron
5-HT3 Receptor Antagonist (Antiemetic)
Pamidronic Acid
Bisphosphonate (Bone Resorption Inhibitor)
Panitumumab
EGFR Inhibitor (Monoclonal Antibody)
Panobinostat
Histone Deacetylase (HDAC) Inhibitor
Pazopanib
Multi-Target Tyrosine Kinase Inhibitor
Pegaspargase
PEGylated Asparaginase (Enzyme)
Pegfilgrastim
Long-Acting G-CSF (Pegylated Colony-Stimulating Factor)
Peginterferon Alfa-2a
Pegylated Interferon Alfa (Immunostimulant)
Pembrolizumab
PD-1 Immune Checkpoint Inhibitor
Pemetrexed
Antifolate Antimetabolite (Multitargeted Antifolate)
Pemigatinib
FGFR Inhibitor (Protein Kinase Inhibitor)
Pentostatin
Adenosine Deaminase Inhibitor (Antineoplastic Antimetabolite)
Pertuzumab
HER2 Dimerisation Inhibitor (Monoclonal Antibody)
Pirtobrutinib
BTK Inhibitor (Non-Covalent Protein Kinase Inhibitor)
Plerixafor
CXCR4 Antagonist (Haematopoietic Stem-Cell Mobiliser)
Polatuzumab Vedotin
CD79b-Directed Antibody-Drug Conjugate
Ponatinib
BCR-ABL Tyrosine Kinase Inhibitor (Protein Kinase Inhibitor)
Procarbazine
Methylhydrazine Derivative (Cytostatic)
Quizartinib
FLT3 Inhibitor (Protein Kinase Inhibitor)
Raltitrexed
Thymidylate Synthase Inhibitor (Antimetabolite, Folate Analogue)
Ramucirumab
VEGFR2 Inhibitor (Monoclonal Antibody)
Rasburicase
Recombinant Urate Oxidase (Uricolytic Enzyme)
Regorafenib
Multi-Kinase Inhibitor (Protein Kinase Inhibitor)
Relugolix
GnRH Receptor Antagonist (Hormone Therapy)
Repotrectinib
ROS1/TRK Kinase Inhibitor (Protein Kinase Inhibitor)
Retifanlimab
PD-1 Inhibitor (Monoclonal Antibody)
Ribociclib
CDK4/6 Inhibitor (Protein Kinase Inhibitor)
Ripretinib
KIT/PDGFRA Inhibitor (Tyrosine Kinase Inhibitor)
Rituximab
Anti-CD20 Monoclonal Antibody (Chimeric IgG1)
Ropeginterferon Alfa-2b
Pegylated Interferon Alfa-2b (Immunostimulant)
Rucaparib
PARP Inhibitor
Ruxolitinib
JAK1/JAK2 Inhibitor (Protein Kinase Inhibitor)
Sacituzumab Govitecan
Trop-2-Directed Antibody-Drug Conjugate
Selinexor
XPO1 Inhibitor (Selective Inhibitor of Nuclear Export)
Selpercatinib
RET Kinase Inhibitor (Protein Kinase Inhibitor)
Selumetinib
MEK1/2 Inhibitor (Protein Kinase Inhibitor)
Serplulimab
PD-1 Inhibitor (Monoclonal Antibody)
Sorafenib
Multikinase Inhibitor (Protein Kinase Inhibitor)
Sotorasib
KRAS G12C Inhibitor (Targeted Therapy)
Sugemalimab
PD-L1 Inhibitor (Monoclonal Antibody)
Sunitinib
Multi-Targeted Receptor Tyrosine Kinase Inhibitor
Tafasitamab
CD19-Directed Monoclonal Antibody
Talazoparib
PARP Inhibitor
Talquetamab
Bispecific T-Cell Engager (GPRC5D/CD3 Antibody)
Tamoxifen
Selective Oestrogen Receptor Modulator (Anti-Oestrogen)
Tarlatamab
DLL3-Directed CD3 T-Cell Engager (Bispecific Antibody)
Tasonermin
Recombinant Tumour Necrosis Factor Alfa (Immunostimulant)
Tebentafusp
Bispecific T-Cell Engager (TCR/Anti-CD3 Fusion Protein)
Teclistamab
Bispecific T-Cell Engager (BCMA/CD3 Antibody)
Tegafur/Gimeracil/Oteracil
Oral Fluoropyrimidine Combination (Antimetabolite)
Telotristat Ethyl
Tryptophan Hydroxylase Inhibitor
Temoporfin
Photosensitiser (Photodynamic Therapy Agent)
Temozolomide
Alkylating Agent (Triazene)
Temsirolimus
mTOR Inhibitor (Protein Kinase Inhibitor)
Tepotinib
MET Kinase Inhibitor (Protein Kinase Inhibitor)
Thiotepa
Alkylating Agent (Nitrogen Mustard-Related)
Thyrotropin Alfa
Recombinant Human TSH (Anterior Pituitary Hormone)
Tioguanine
Purine Antimetabolite (Thiopurine)
Tislelizumab
PD-1 Inhibitor (Monoclonal Antibody)
Tisotumab Vedotin
Antibody-Drug Conjugate (Tissue Factor-Directed)
Tivozanib
VEGF Receptor Tyrosine Kinase Inhibitor
Topotecan
Topoisomerase I Inhibitor (Camptothecin Derivative)
Toremifene
Anti-Oestrogen (Triphenylethylene Derivative)
Toripalimab
PD-1 Inhibitor (Monoclonal Antibody)
Tovorafenib
RAF Kinase Inhibitor (Protein Kinase Inhibitor)
Trabectedin
Antineoplastic Agent (DNA Minor-Groove Binder)
Trametinib
MEK Inhibitor (Protein Kinase Inhibitor)
Trastuzumab
HER2-Directed Monoclonal Antibody
Trastuzumab Deruxtecan
HER2-Directed Antibody-Drug Conjugate
Trastuzumab Emtansine
HER2-Targeted Antibody-Drug Conjugate
Tremelimumab
CTLA-4 Inhibitor (Monoclonal Antibody)
Treosulfan
Alkylating Agent (Conditioning Treatment)
Tretinoin
Retinoid (Vitamin A Derivative)
Trifluridine/Tipiracil
Antimetabolite (Nucleoside Analogue With Thymidine Phosphorylase Inhibitor)
Triptorelin
GnRH Agonist (Gonadotropin-Releasing Hormone Analogue)
Tucatinib
HER2 Tyrosine Kinase Inhibitor (Protein Kinase Inhibitor)
Vandetanib
Tyrosine Kinase Inhibitor (VEGFR, EGFR and RET)
Vemurafenib
BRAF Inhibitor (Protein Kinase Inhibitor)
Vimseltinib
CSF1R Inhibitor (Tyrosine Kinase Inhibitor)
Vinblastine
Vinca Alkaloid (Cytostatic)
Vincristine
Vinca Alkaloid Chemotherapy
Vinflunine
Vinca Alkaloid (Microtubule Inhibitor)
Vinorelbine
Vinca Alkaloid (Microtubule Inhibitor)
Vorasidenib
Mutant IDH1/IDH2 Inhibitor
Zanidatamab
HER2-Targeted Bispecific Antibody (Monoclonal Antibody)
Zanubrutinib
BTK Inhibitor (Protein Kinase Inhibitor)
Zolbetuximab
CLDN18.2-Targeted Monoclonal Antibody
Zoledronic Acid
Nitrogen-Containing Bisphosphonate (Bone Resorption Inhibitor)
Other therapeutic areas
Get in Touch with Our Team
Two ways to reach us — quick or detailed.
Personal reply within 48 hours
EU-licensed operations · global sourcing
No automated quotes
In a hurry?
Quick request
Your name and phone number — done in 30 seconds. We'll get back to you and take it from there.
Want a full answer right away?
Detailed request
Share the medication, country, and your preferences — we reply once, with availability, requirements, and delivery options.
Or reach us directly: +43 660 5464386 · contact@pharmalogistic.eu